Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

From Cystic Fibrosis to COVID-19: A Medical Solution Like No Other

(Image via Dymedso Inc.) Airway clearance therapy has been a cornerstone of treatments aimed at minimizing the devastating effects of airway obstruction, infection, and inflammation caused by a buildup of mucus in lung conditions … but finding a non-invasive solutio...
Stockhouse Editorial | December 8, 2020 |

Biopharma to Test Immunity Activator in Advanced Solid Cancers

The company's plans for and approach to one of its most advanced drug candidates are discussed in an H.C. Wainwright & Co. report. In a Dec. 12 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that BioXcel Therapeutics Inc. (BTAI:NASDAQ) plans to ...
Streetwise Reports | December 19, 2019 |

BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

In the past, people have accepted that it usually takes about ten years to get a vaccine on the market. Careful testing with proof of success is required for a preparation to receive approvals. Since COVID-19, the pressure to develop has increased dramatically and also the pot...
Mario Hose | September 1, 2020 |

A Bold Innovator in Tactical & Defense Security

(Image via KWESST Inc.) KWESST Inc. ( TSX-V: FMV.P ) is a Canadian military tech Company that “makes dumb weapons smart” by developing proprietary technology for the military and homeland security markets. Its Executive Chairman David Luxton wa...
Featured Submission | September 9, 2020 |

Buzz on the Bullboards: Stocks to watch as TSX hits new highs

This week, the TSX experienced a roller-coaster of wins and losses, yet managed to break a record high. In the face of this dynamic trading environment, three companies have stood out for their notable achievements and promising outlooks. When the Clevela...
Jonathon Brown | October 17, 2024 |

Buzz on the Bullboards: Feeling holiday blues, or celebrating blue chip stocks?

Are you anticipating a calm market as the holidays approach? Think again. Astute investors and brokers recognize that this is their moment to excel. With the global economy constantly shifting, staying active is the smart move. Over the past week, some shareholde...
Jonathon Brown | 13 days ago |

From COVID to Nicotine Treatments, this Bio Stock is One to Watch

(Image via Lexaria Bioscience Corp.) There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented tech...
Stockhouse Editorial | December 1, 2020 |

MLP Achieves 'Another Beat and Raise' in Q2/19

Performance during the quarter and guidance for the rest of 2019 are reviewed in a Raymond James report. In an Aug. 1 research note, Raymond James analyst Justin Jenkins reported that Magellan Midstream Partners L.P.'s (MMP:NYSE) Q2/19 results are positive,...
Streetwise Reports | August 7, 2019 |

Texas Oil & Gas Company's Production Up, Costs Down in Q2/19

A review of the firm's quarterly operational and financial results is given in a Raymond James report. In an Aug. 2 research note, Raymond James analyst John Freeman reported that Noble Energy Inc. (NBL:NYSE) delivered a "strong Q2/19." He provided the...
Streetwise Reports | August 7, 2019 |

Senior Gold Miner Is On Track for a 'Strong H2/19'

The company's Q2/19 operational and financial results are reviewed in a BMO Capital Partners report. In an Aug. 8 research note, BMO Capital Markets analyst Andrew Kaip reported that AngloGold Ashanti Ltd. (AU:NYSE; ANG:JSE; AGG:ASX; AGD:LSE) is "well positioned for...
Streetwise Reports | August 14, 2019 |
1 2 3 4 5 6 7 8 9 10 ...